(Q39217541)

10 September 2017

title

Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation (English)

1 reference

10 September 2017

1 reference

Hui-chan He

1

1 reference

10 September 2017

Xiao-hui Ling

2

1 reference

10 September 2017

Jian-guo Zhu

3

1 reference

10 September 2017

Xin Fu

4

1 reference

10 September 2017

Zhao-dong Han

5

1 reference

10 September 2017

Yu-xian Liang

6

1 reference

10 September 2017

Ye-han Deng

7

1 reference

10 September 2017

Zhuo-yuan Lin

8

1 reference

10 September 2017

Guo Chen

9

1 reference

10 September 2017

Yan-fei Chen

10

1 reference

10 September 2017

Ru-jun Mo

11

1 reference

10 September 2017

Wei-de Zhong

12

1 reference

10 September 2017

publication date

3 January 2013

1 reference

Molecular Biology Reports

10 September 2017

published in

1 reference

10 September 2017

volume

40

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

3799-3805

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-012-2458-2

10 September 2017

exact match

0 references

cites work

ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

The ERBB3 receptor in cancer and cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Targeting ErbB receptors in high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Potential therapeutic strategy for oral squamous cell carcinoma by ErbB3-binding protein 1 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2458-2

Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.

21 January 2018

1 reference

12 December 2020

Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis

1 reference

12 December 2020

Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes

1 reference

12 December 2020

EBP1 inhibits translation of androgen receptor mRNA in castration resistant prostate cancer cells.

1 reference

12 December 2020

Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome

1 reference

12 December 2020

10.1007/S11033-012-2458-2

Identifiers

DOI

1 reference

release_l4ulhijmrvexfbalpxp3cmbikm

10 September 2017

Fatcat ID

0 references

1 reference